| Literature DB >> 22936185 |
Monir Doudi1, Mahbubeh Setorki, Manizheh Narimani.
Abstract
BACKGROUND: Zoonotic Cutaneous Leishmaniasis (ZCL) is a polymorphic disease. It is generally accepted that bacterial superinfection may play a role in the clinical appearance of the lesions and may delay or prevent the healing process. However, the pattern of bacterial pathogens involved has rarely been investigated. MATERIAL/Entities:
Mesh:
Substances:
Year: 2012 PMID: 22936185 PMCID: PMC3560647 DOI: 10.12659/msm.883345
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
The clinical feature of 3 different forms of ZCL present in Borkhar area, Isfahan, Iran.
| Type of ZCL | Main characteristics | Size | Duration | Site |
|---|---|---|---|---|
| Volcano-shape | Raised turgid margins. Central serous crust Resembles to a flattened Volcano. Painless | 2–3 | 2–4 | Face, Foot |
| Psoriasiform | Superficial with raised patches of skin covered with silvery scales Resembles psoriasis, Painless Firm-levated erythematous | 6–8 | 2–4 | Face |
| Papular form | Papule with exudative Surface, Plainless | <0.5 | 3–4 | Upper arm |
The shape was named according to Griffithis (1987);
size of ulcerated area expressed in cm;
number of weeks after first appearance of the lesions according to the patients;
the most common site of the lesions.
Prevalence of clinically different forms of ZCL and the distribution of bacterial superinfection in Borkhar area Isfahan, Iran.
| Type of ZCL | Number and% of patients | ||
|---|---|---|---|
| Total | Infected | Non infected | |
| Volcano-shape | 502 (83.4) | 355 (88.3) | 147 (73.5) |
| Psoriasiform | 53 (8.8) | 32 (8) | 21 (10.3) |
| Popular form | 40 (6.6) | 10 (2.5) | 30 (15) |
| Other atypical form | 7 (1.2) | 5 (1.2) | 2 (1) |
| Total | 602 (100) | 402 (100) | 200 (100) |
Figures in brackets are percentages.
Bacterial species isolated from ZCL and non-ZCL lesions in Borkhar area Isfahan, Iran.
| Bacterial | ZCL lesions %n=453 | Non-ZCL Lesions %n=415 |
|---|---|---|
| 189 (41.7)* | 170 (41) | |
| 127 (28) | 110 (26.5) | |
| 36 (7.9) | 10 (2.4) | |
| 30 (6.6) | 27 (6.5) | |
| 24 (5.3) | 20 (4.8) | |
| 19 (4.2) | 38 (9.2) | |
| 11 (2.4) | 10 (2.4) | |
| 10 (2.2) | 20 (4.8) | |
| 7 (1.5) | 10 (2.4) |
Bacterial species isolated from 3 clinically different forms of ZCL.
| Volcano-shape | Psoriasiform | Popular form |
|---|---|---|
Percentage resistance of bacteria isolated form ZCL lesions to common antibiotics.
| Antibiotics | Gram Positive Bacteria | Gram Negative Bacteria | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Sa | Se | Sp | Bs | Ec | Ks | Es | Pa | Ps | |
| Amoxcillin | 87 | 89 | 17 | 41 | 99 | 60 | 94 | 91 | 94 |
| Ampicillin | 92 | 85 | 14 | 49 | 95 | 86 | 10 | 91 | 92 |
| Cefazolin | 12 | 20 | 10 | 27 | 20 | 18 | 16 | 25 | 11 |
| Ceftizoxime | 25 | 18 | 11 | 19 | 30 | 38 | 50 | 85 | 71 |
| Cephalothin | 13 | 11 | 20 | 28 | 65 | 62 | 51 | 75 | 38 |
| Ciprofloxacin | 8 | 10 | 12 | 14 | 20 | 17 | 13 | 13 | 15 |
| Clindomycin | 40 | 45 | 36 | 26 | 20 | 11 | 15 | 13 | 14 |
| Cloxacillin | 45 | 24 | 18 | 11 | 38 | 29 | 25 | 14 | 12 |
| Chloramphenicol | 60 | 50 | 35 | 43 | 50 | 70 | 81 | 93 | 85 |
| Cotrimaxozole | 83 | 90 | 35 | 35 | 80 | 78 | 70 | 91 | 93 |
| Erythromycin | 12 | 19 | 22 | 10 | 60 | 58 | 27 | 53 | 51 |
| Gentamycin | 36 | 30 | 20 | 12 | 55 | 60 | 29 | 71 | 59 |
| Kanamycin | 30 | 25 | 10 | 13 | 55 | 38 | 31 | 53 | 15 |
| Neomycin | 23 | 22 | 12 | 10 | 30 | 32 | 20 | 30 | 49 |
| Penicillin | 96 | 90 | 8 | 21 | 93 | 94 | 92 | 97 | 98 |
| Tetracycline | 71 | 63 | 35 | 43 | 89 | 60 | 81 | 62 | 69 |
Sa – Staphylococcus aureus; Se – Staphylococcus epidermidis; Sp – Streptococcus pyogenes; Bs – Bacillus sp.; Ec – Escherichia coli; Ks – Klebsiella sp.; Es – Entrobacter sp.; Pa – Pseudomonas aeroginosa; Ps – Proteus sp.
Figure 1Volcano shape.
Figure 3Popular form.